ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes - Fierce Biotech
ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes Fierce Biotech
Zepbound News
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk - ScienceDaily
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk ScienceDaily
A new wave of weight-loss therapies aims to be better than today’s GLP-1s - MarketWatch
A new wave of weight-loss therapies aims to be better than today’s GLP-1s MarketWatch
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans - CNBC
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans CNBC
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash - NBC News
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash NBC News
Exclusive: Cigna drops coverage of GLP-1 obesity drugs for its own employees - Reuters
Exclusive: Cigna drops coverage of GLP-1 obesity drugs for its own employees Reuters
A new Medicare option for weight loss drugs is coming: Here's what to know - NPR
A new Medicare option for weight loss drugs is coming: Here's what to know NPR
CVS will add these weight-loss options to drug plans - USA Today
CVS will add these weight-loss options to drug plans USA Today
‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound? - Healthline
‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound? Healthline
CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo - Fierce Pharma
CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo Fierce Pharma
Foundayo and Zepbound now covered for millions of Americans | Eli Lilly and Company - investor.lilly.com
Foundayo and Zepbound now covered for millions of Americans | Eli Lilly and Company investor.lilly.com
Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests - Reuters
Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests Reuters
Will Zepbound get cheaper? Ways to lower your costs now - Medical News Today
Will Zepbound get cheaper? Ways to lower your costs now Medical News Today
Some Medicare recipients may soon get Wegovy, Zepbound for $50 a month - Click2Houston
Some Medicare recipients may soon get Wegovy, Zepbound for $50 a month Click2Houston
CVS Returns Zepbound to Drug Plans After Lilly Slashes Price - Bloomberg
CVS Returns Zepbound to Drug Plans After Lilly Slashes Price Bloomberg
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials - PR Newswire
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials PR Newswire
My friend lost 30 lbs on Zepbound , and then had to cut her hair off. Now she's trying this instead. - Yahoo Creators
My friend lost 30 lbs on Zepbound , and then had to cut her hair off. Now she's trying this instead. Yahoo Creators
Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it - NPR
Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it NPR
CVS Caremark to cover Zepbound again after lawsuit, widespread backlash - LiveNOW from FOX
CVS Caremark to cover Zepbound again after lawsuit, widespread backlash LiveNOW from FOX
More Health Insurance Companies May Soon Cover the GLP-1 Obesity Drugs Zepbound and Foundayo - Everyday Health
More Health Insurance Companies May Soon Cover the GLP-1 Obesity Drugs Zepbound and Foundayo Everyday Health
Lilly Is Just Getting Started With Zepbound In Autoimmune Disease - Citeline News & Insights
Lilly Is Just Getting Started With Zepbound In Autoimmune Disease Citeline News & Insights
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - investor.lilly.com
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen investor.lilly.com
CVS brings back coverage for Lilly's obesity drug Zepbound - Reuters
CVS brings back coverage for Lilly's obesity drug Zepbound Reuters
CVS reopens door to Lilly's Zepbound, adds newly launched Foundayo - FirstWord Pharma
CVS reopens door to Lilly's Zepbound, adds newly launched Foundayo FirstWord Pharma
Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect - investor.lilly.com
Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect investor.lilly.com
How To Get Zepbound: Eligibility Criteria And Where To Buy - Forbes
How To Get Zepbound: Eligibility Criteria And Where To Buy Forbes
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo - Pharmaceutical Executive
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo Pharmaceutical Executive
Wegovy and Zepbound Could Reduce the Risk of Needing Knee Replacement - Everyday Health
Wegovy and Zepbound Could Reduce the Risk of Needing Knee Replacement Everyday Health
Zepbound’s and Ozempic’s greatest benefit may be their anti-inflammatory power - Scientific American
Zepbound’s and Ozempic’s greatest benefit may be their anti-inflammatory power Scientific American
Restrictions on obesity drug coverage force patients to pivot - NPR
Restrictions on obesity drug coverage force patients to pivot NPR
Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better - The Motley Fool
Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better The Motley Fool
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight - investor.lilly.com
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight investor.lilly.com
Boehringer’s weight loss jab as good as Wegovy but not Zepbound - Clinical Trials Arena
Boehringer’s weight loss jab as good as Wegovy but not Zepbound Clinical Trials Arena
Zepbound Vs. Ozempic For Weight Loss: What’s The Difference? - Forbes
Zepbound Vs. Ozempic For Weight Loss: What’s The Difference? Forbes
CVS Health to Offer Zepbound and Foundayo | PharmExec - Pharmaceutical Executive
CVS Health to Offer Zepbound and Foundayo | PharmExec Pharmaceutical Executive
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen - CNBC
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen CNBC
Lilly's Foundayo and Zepbound to gain CVS coverage, lifting sales outlook - Endpoints News
Lilly's Foundayo and Zepbound to gain CVS coverage, lifting sales outlook Endpoints News
Eli Lilly launches new weight-loss drug Zepbound KwikPen: What to know - ABC News - Breaking News, Latest News and Videos
Eli Lilly launches new weight-loss drug Zepbound KwikPen: What to know ABC News - Breaking News, Latest News and Videos
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight - PR Newswire
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight PR Newswire
Is There a Generic for Zepbound? - Ro
Is There a Generic for Zepbound? Ro